Evidence map›Paper›PMID 31838197›Full record

ArticleProstaglandins & other lipid mediators2020

Urinary prostaglandin E

Tarak Srivastava, Wenjun Ju, Ginger L Milne, Mohamed H Rezaiekhaligh, Vincent S Staggs, Uri S Alon, Ram Sharma, Jianping Zhou, Ashraf El-Meanawy, Ellen T McCarthy and 2 more

Open access · greenAbstract read
In one paragraph

Article in Prostaglandins & other lipid mediators, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Prostanoid receptors in hyperfiltration-mediated glomerular injury: Novel agonists and antagonists reveal opposing roles for EP2 and EP4 receptors.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022
    Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 1 country.

Tarak SrivastavaDivision of Nephrology, Children's Mercy Hospital and University of Missouri at Kansas City, Kansas City, MO, United States; Research and Development, Nephrology, Kansas City VA Medical Center, Kansas City, MO, United States. Electronic address: tsrivastava@cmh.edu.
Wenjun JuDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, United States.
Ginger L MilneDivision of Clinical Pharmacology, Vanderbilt University, Nashville, TN, United States.
Mohamed H RezaiekhalighDivision of Nephrology, Children's Mercy Hospital and University of Missouri at Kansas City, Kansas City, MO, United States.
Vincent S StaggsBiostatistics & Epidemiology Core, Children's Mercy Kansas City, Department of Pediatrics, University of Missouri, Kansas City, United States.
Uri S AlonDivision of Nephrology, Children's Mercy Hospital and University of Missouri at Kansas City, Kansas City, MO, United States.
Ram SharmaResearch and Development, Nephrology, Kansas City VA Medical Center, Kansas City, MO, United States.
Jianping ZhouResearch and Development, Nephrology, Kansas City VA Medical Center, Kansas City, MO, United States; Midwest Biomedical Research Foundation (MBRF), KCVA Medical Center, Kansas City, MO, United States.
Ashraf El-MeanawyDivision of Nephrology, Medical College of Wisconsin, Milwaukee, WI, United States.
Ellen T McCarthyKidney Institute, Kansas University Medical Center, Kansas City, KS, United States.
Virginia J SavinResearch and Development, Nephrology, Kansas City VA Medical Center, Kansas City, MO, United States; Kidney Institute, Kansas University Medical Center, Kansas City, KS, United States.
Mukut SharmaResearch and Development, Nephrology, Kansas City VA Medical Center, Kansas City, MO, United States; Midwest Biomedical Research Foundation (MBRF), KCVA Medical Center, Kansas City, MO, United States; Kidney Institute, Kansas University Medical Center, Kansas City, KS, United States.
Kansas City VA Medical Center · USChildren's Mercy Hospital · USMedical College of Wisconsin · USMidwest Biomedical Research Foundation · USUniversity of Kansas Medical Center · USUniversity of Michigan–Ann Arbor · USVanderbilt University · US

Funding

Targeting PGE2 Receptors to attenuate shear stress-induced glomerular injuryR01DK107490 · NIDDK · CHILDREN'S MERCY HOSP (KANSAS CITY, MO) · PI SRIVASTAVA, TARAK · 2016 to 2020
$2.0M
CYTOCHROME P-450 AND GLOMERULAR PROTEIN PERMEABILITYR01DK064969 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI MCCARTHY, ELLEN T · 2005 to 2010
$1.7M
BLRD VA I01 BX001037NIDDK NIH HHS R01 DK064969NIDDK NIH HHS R01 DK107490
6 · The paper itself

Abstract

introductionHyperfiltration is a major contributor to progression of chronic kidney disease (CKD) in diabetes, obesity and in individuals with solitary functioning kidney (SFK). We have proposed hyperfiltration-induced injury as a continuum of overlapping glomerular changes caused by increased biomechanical forces namely, fluid flow shear stress (FFSS) and tensile stress. We have shown that FFSS is elevated in animals with SFK and, it upregulates prostaglandin E

methodsUrine samples from children with SFK and controls were analyzed for PGE

resultsChildren with SFK were comparable to controls except for lower BMI Z-scores. The median values were elevated in SFK compared to control for urine PGE

conclusionIncreased urinary PGE

Indexed as

Glomerular Filtration RateAdolescentBiomarkersChildChild, PreschoolDinoprostoneFemaleHumansInfantKidney GlomerulusMaleRenal Insufficiency, ChronicYoung AdultBiomarkersDinoprostoneAlbuminuriaEpidermal growth factorFluid flow shear stressHyperfiltrationProstaglandin E(2)

Identifiers

PMID31838197
PMCPMC9356765
OpenAlexW2996159126

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.